CNBC - INDIANAPOLIS - Eli Lilly & Co. said Thursday its third-quarter profit rose percent on strong sales of drugs such as its Cymbalta depression treatment, and it raised its outlook for the year. The drug maker said net income rose 6 percent to $926.3 ...
